Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases: protocol of the multicentre, open-label, phase II, INTERACT-II trial.
Vincent van de VlasakkerNiels A D GuchelaarTeun B M van den HeuvelRobin J LurvinkEsther van MeertenRamon J F BaxGeert-Jan M CreemersIrene E G van HellemondAlexandra R M Brandt-KerkhofEva V E MadsenJoost NederendStijn L W KoolenSimon W NienhuijsOnno KranenburgIgnace H J T de HinghCornelis VerhoefRon H J MathijssenJacobus W A Burgernull nullnull nullPublished in: BMJ open (2024)
NCT06003998.